禁煙・脱ニコチン中毒製品の世界市場：産業分析、規模、シェア、成長率、動向および予測

当レポートでは、世界の禁煙・脱ニコチン中毒製品市場について調査し、市場概要、タイプ・地域別の市場分析と予測、競合情勢の分析、および主要企業のプロファイルなどをまとめ、提供しています。

第1章 序文

第2章 エグゼクティブサマリー

第3章 産業分析：禁煙・脱ニコチン中毒製品市場

• イントロダクション・市場定義
• 市場ダイナミクス
  • 促進因子
  • 抑制因子
  • 機会
• 市場の魅力分析：地域別
• 競合情勢：ヒートマップ分析

第4章 禁煙・脱ニコチン中毒製品市場区分：タイプ別

• 世界の禁煙・脱ニコチン中毒製品市場収益：タイプ別
• 世界の禁煙・脱ニコチン中毒製品市場収益：ニコチン代用療法別
  • ニコチンガム市場収益・分析
  • ニコチンパッチ市場収益・分析
  • ニコチンスプレー市場収益・分析
  • ニコチン吸入薬市場収益・分析
  • ニコチントローチ剤市場収益・分析
  • ニコチン舌下錠市場収益・分析
• 世界の禁煙・脱ニコチン中毒製品市場収益：薬物療法別
  • ブプロピオン (Zyban) 市場収益・分析
  • バレニクリン (Champix, Chantix) 市場収益・分析
• 世界の電子たばこ (eシガレット) 市場収益

第5章 禁煙・脱ニコチン中毒製品市場区分：地域別

• 世界の禁煙・脱ニコチン中毒製品市場収益：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 企業プロファイル

• Cipla Ltd.
• GlaxoSmithKline plc
• Imperial Tobacco Company of India Limited.
• McNeil AB
• NJOY, Inc.
• Novartis International AG
• Pfizer, Inc.
• Revolymer PLC
• 武田薬品工業

Global Smoking Cessation and Nicotine De-addiction Products Market: Overview

The smoking cessation and nicotine de-addiction products market report is a veritable guide for its offerings. The report includes detailed insights into growth indices and development trends in the smoking cessation and nicotine de-addiction products market for the 2017-2023 forecast time frame by segmenting in terms of drug type and geography. For the study, 2016 is considered as the base year and 2015 values have been provided for historical reference. The report provides revenues estimations in US$ Mn and volume estimations in Kilo tons for the 2017-2023 forecast period.

The executive summary section begins with an outline of definitions, notations, and conventions that are relevant to smoking cessation market. This is followed by detailed insights into large smoking cessation programs and rehabilitation programs that have been organized globally by welfare bodies. Details about different smoking cessation programs along with de-addiction products used are also provided herein.

The section continues with a discussion on vital market indicators such as demand drivers and opportunities that are likely to come to the fore in the smoking cessation and nicotine de-addiction products market. Following this, the qualitative and quantitative aspects of some other growth indicators such as investments and price trends that are likely to impact the smoking cessation and nicotine de-addiction products market have been discussed at length. Insights into distribution and trade scenario, company market share, Porter's five forces analysis, value chain analysis, and attractiveness analysis for key end users are some other highlights of this report.

Global Smoking Cessation and Nicotine De-addiction Products Market: Research Methodology

The report is a perfect example of combination of primary and secondary research methodologies. Analysts employed standard industry-best analytical tools and proven research methodologies in the making of the report. Using this approach analysts calculated revenue estimates and market share estimates of key product and application segments over the forecast period. Analysts reached out to industry experts and key opinion leaders in the primary research phase via e-mail, telephonic interviews, and face-to-face interviews. Analysts interacted with industry experts on an ongoing basis to endorse data and analysis.

Secondary research sources reached out include annual reports, financial reports, company websites, investor presentations, broker reports, and SEC filings. In addition, some other secondary sources include pertinent licensed and regulatory databases, market reports, internal and external proprietary databases, news articles, trade journals, business publications, government documents, press releases, and webcasts specifically created for companies.

Following an extensive primary and secondary research phase, growth trends that are expected to come to the fore through 2024 are based on the following assumptions;

The study is limited to demand for smoking cessation and nicotine de-addiction products for key applications in key regions

Market projections have been provided with the assumption that there would not be serious political disturbances or environmental calamities that could impact the growth of smoking cessation and nicotine de-addiction products market

Overall revenue estimate of smoking cessation and nicotine de-addiction products market has been provided aggregating the revenue contribution of key drug types in key regions

Table of Contents

1. Preface

2. Executive Summary

• 2.1. Introduction
• 2.2. Global Smoking Cessation and Nicotine De-addiction Products Market: Market Snapshot
• 2.3. Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography and Analysis

3. Industry Analysis: Smoking Cessation and Nicotine De-addiction Products Market

• 3.1. Introduction and Market Definition
• 3.2. Market Dynamics
  • 3.2.1. Drivers
    • 3.2.1.1. Rising awareness about smoking health hazards and smoking cessation therapy
    • 3.2.1.2. Introduction of new products
    • 3.2.1.3. Reimbursement for smoking cessation therapy
  • 3.2.2. Restraints
    • 3.2.2.1. Low awareness about smoking cessation products in developing economies
    • 3.2.2.2. Legal obligations dragging growth of several smoking cessation product segments
  • 3.2.3. Opportunity
    • 3.2.3.1. Research and development
    • 3.2.3.2. Market expansion in developing economies
• 3.3. Market Attractiveness Analysis of Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography
• 3.4. Competitive Landscape: Heat Map Analysis

4. Smoking Cessation and Nicotine De-addiction Products Market Segmentation - by Type

• 4.1. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn)
• 4.2. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Nicotine Replacement Therapies, 2013-2023 (US$ Mn)
  • 4.2.1. Global Nicotine Gums Market Revenue, 2013-2023, (US$ Mn) and Analysis
  • 4.2.2. Global Nicotine Patches Market Revenue, 2013-2023, (US$ Mn) and Analysis
  • 4.2.3. Global Nicotine Sprays Market Revenue, 2013-2023, (US$ Mn) and Analysis
  • 4.2.4. Global Nicotine Inhalers Market Revenue, 2013-2023, (US$ Mn) and Analysis
  • 4.2.5. Global Nicotine Lozenges Market Revenue, 2013-2023, (US$ Mn) and Analysis
  • 4.2.6. Global Nicotine Sub lingual Tablets Market Revenue, 2013-2023, (US$ Mn) and Analysis
• 4.3. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Drug Therapy, 2013-2023 (US$ Mn)
  • 4.3.1. Global Bupropione (Zyban) Market Revenue, 2013-2023, (US$ Mn) and Analysis
  • 4.3.2. Global Varenicline (Champix, Chantix) Market Revenue, 2013-2023, (US$ Mn)
• 4.4. Global E- Cigarettes Market Revenue, 2013-2023, (US$ Mn)

5. Smoking Cessation and Nicotine De-addiction Products Market Segmentation - by Geography

• 5.1. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Geography, 2013-2023 (US$ Mn)
• 5.2. North America
  • 5.2.1. North America Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
  • 5.2.2. North America Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis
• 5.3. Europe
  • 5.3.1. Europe Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
  • 5.3.2. Europe Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis
• 5.4. Asia Pacific
  • 5.4.1. Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
  • 5.4.2. Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis
• 5.5. Rest of the World
  • 5.5.1. Rest of the World Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
  • 5.5.2. Rest of the World Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis

6. Company Profiles

• 6.1. Cipla Ltd.
• 6.2. GlaxoSmithKline plc
• 6.3. Imperial Tobacco Company of India Limited.
• 6.4. McNeil AB
• 6.5. NJOY, Inc.
• 6.6. Novartis International AG
• 6.7. Pfizer, Inc.
• 6.8. Revolymer PLC
• 6.9. Takeda Pharmaceutical Co., Ltd.